Welcome to Integrated Oncology

Home Page - Slider

Working with Integrated Oncology
Oncology Testing
VistaSeq Hereditary Cancer Testing
For Patients
working with integrated oncology
Working with Integrated Oncology

More than 25 years of testing experience and expertise

Oncology Testing

Evolving personalize testing for you

vistaseq
VistaSeq Hereditary Cancer Testing

Because Knowledge is a Powerful Tool

for patients
For Patients

Dedicated to helping educate patients and inform the public about oncology diagnostic testing.

For Patients

www.mytestingoptions.com

Prepare for visits with your doctor or a genetic counselor by learning about testing.

Working with Integrated Oncology

News

LabCorp announces new agreements with UnitedHealthcare and Aetna
Read more

Integrated Oncology Highlights

NTRK Gene Fusions

TRK fusion proteins are oncogenic drivers that occur in a broad range of tumors across adult and pediatric cancers.  Genomic profiling using either the OmniSeq AdvanceSM assay or the OmniSeq Comprehensive® assay can identify actionable NTRK gene fusions for TRK inhibitor treatment selection.

OmniSeq Advance Assay

NEW test offering - The OmniSeq AdvanceSM assay is a single test that combines the benefits of both targeted immunotherapy and genomic biomarkers to inform the therapeutic management of cancer patients under consideration for checkpoint inhibition or targeted therapy.  Learn more.

OmniSeq Immune Report Card® Assay

NEW test offering - The OmniSeq Immune Report Card assay supports immunotherapy treatment decision making by providing comprehensive immune profiling from a single sample.  Learn more.

OmniSeq Comprehensive® Assay

NEW test offering - OmniSeq Comprehensive next-gen molecular sequencing assay, identifying somatic variants in 144 genes.  Learn more.